# Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs

> **NCT01543035** · PHASE3 · COMPLETED · sponsor: **Calmy Alexandra** · enrollment: 34 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** stop statin and switch to an antiretroviral drug with less impact on lipid metabolism

## Key facts

- **NCT ID:** NCT01543035
- **Lead sponsor:** Calmy Alexandra
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01543035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01543035, "Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01543035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*